Global Dry Powder Inhalation Developments and Products Report 2022: Nicotine, Cannabinoids, Botanicals and Other Non-Medical Substances Delivery by…

DUBLIN--(BUSINESS WIRE)--The "Dry Powder Inhalation Developments and Products In Scope of Nicotine, Cannabinoids, Botanicals and Other Non-Medical Substances Delivery, Designed By Big Tobacco and Pharmaceutical Companies - Market Overview Report for 1994-2022" report has been added to ResearchAndMarkets.com's offering.

Dry powder inhalation technology is an efficient method for delivering nicotine, cannabis-based drugs, stimulants and botanicals by major pharmaceutical and Big Tobacco companies.

Philip Morris International, British American Tobacco and Imperial Brands (Nerudia Ltd.) were actively engaged in the development of dry powder inhalation technology. These companies applied fundamentally different approaches to dry powder inhalation devices and their developments are at various stages: canceled, under-development, clinical trials, etc.

Dry powder inhalation technology provides a number of undoubted benefits. Dry powder formulations provide faster dissolution and absorption of the nicotine/cannabis/alternative formulations. Dry powder inhalers feature battery-free design, precise dose control and low-cost manufacturing.

Among a variety of designs for dry powder inhalers, multi-dose (reservoir) and multi-unit dose (blister) inhalers are considered to be prospective pharmaceutical platforms for inhalation delivery of nicotine, cannabis, stimulants and botanical formulations.

This report provides an overview of dry powder inhalation as an alternative delivery technology for nicotine, cannabis and alternative botanical and stimulant substances along with the analysis of existing solutions and prospective concepts of dry powder inhalation devices.

Report Scope

.Key Topics Covered:

Scope of the report

Executive Summary

1. Dry powder inhalation technology perspectives

2. Dry powder inhalation developments by Big Tobacco and their subsidiaries

2.1 PMI's dry powder inhalation developments

2.2 BAT's dry powder inhalation developments

2.3 Imperial Brands' dry powder inhalation developments

3. Dry powder inhalable formulations

3.1 Inhalable formulations with nicotine

3.2 Inhalable formulations with cannabinoids

3.3 Inhalable formulations with alternative substances

4. Prospective concepts of cannabis and nicotine dry powder inhalers

4.1 Single-unit dose (disposable) dry powder inhalers

4.2 Single-unit dose (capsule) dry powder inhalers

4.3 Multi-dose (reservoir) dry powder inhalers

References

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/1lm7xf

Read more from the original source:
Global Dry Powder Inhalation Developments and Products Report 2022: Nicotine, Cannabinoids, Botanicals and Other Non-Medical Substances Delivery by...